Breaking News Instant updates and real-time market news.

MRK

Merck

$87.43 /

-0.97 (-1.10%)

19:54
10/06/22
10/06
19:54
10/06/22
19:54

Merck, Ridgeback Biotherapeutics provide update on studies of Lagevrio

Merck and Ridgeback Biotherapeutics "issued the following announcement regarding data from two real-world evidence studies evaluating LAGEVRIO, or molnupiravir, an investigational oral antiviral COVID-19 medicine. The first study, PANORAMIC, was conducted by the University of Oxford in the UK in highly-vaccinated adults mostly less than age 65 during the period when the circulating SARS-CoV-2 variant was predominantly Omicron. The second study, Clalit, was conducted by investigators in Israel in mostly older adults with underlying chronic health conditions that make them vulnerable to severe COVID-19 disease, also when Omicron was the most dominant strain. The PANORAMIC pre-print was published today and the Clalit pre-print was published last week. Additionally, Merck is reporting results from a recent carcinogenicity study in transgenic mice, which demonstrated that LAGEVRIO was not carcinogenic at any dose tested. The PANORAMIC study, a UK-based clinical trial sponsored by the University of Oxford, included 25,783 participants who were randomized to open label treatment with LAGEVRIO plus usual care or usual care alone; mean age of participants was 56.6 years. Primary outcome data were available in 25,000 participants. Nearly all participants were vaccinated, with approximately 95% receiving three or more doses of a SARS-CoV-2 vaccine. In the preliminary analysis, the primary endpoint of reduction of hospitalizations and deaths within 28 days of randomization, compared to usual care, was not met; 0.8% of patients in both the LAGEVRIO group and the usual care group were hospitalized or died in the first 28 days. On secondary objectives, LAGEVRIO was associated with improvement on a range of measures compared to usual care. The observed median time to first self-reported recovery was 6 days shorter in the LAGEVRIO group; the median time to first recovery was 9 days on LAGEVRIO vs. 15 days on usual care (range 7 to not reached). Following adjustment for age and baseline comorbidity, there was a substantial estimated improvement of 4 days in time-to-first recovery in the LAGEVRIO group vs. usual care group. The finding on time-to-first recovery was consistent for LAGEVRIO across key subgroups. Secondary objectives were not adjusted for multiplicity. Results from the Clalit study: In this observational, retrospective cohort study, LAGEVRIO was associated with a lower rate of hospitalizations and mortality due to COVID-19 in patients 65 years and above, but not in younger adults. In patients 65 years of age and above, hospitalizations related to COVID-19, the primary endpoint, occurred in 18 LAGEVRIO-treated patients and in 513 untreated patients; adjusted hazard ratio for hospitalization was 0.55. The secondary endpoint of death due to COVID-19 in this same age group occurred in 4 of 845 LAGEVRIO-treated and 137 of 12,724 untreated patients; adjusted HR=0.26. In patients 40 to 64 years of age, hospitalizations related to COVID-19, the primary endpoint, occurred in 8 treated patients and 97 untreated patients , and adjusted HR for hospitalization was 1.80. The secondary endpoint of death due to COVID-19 in this same age group occurred in 4 of 224 LAGEVRIO-treated and 7 of 6,075 untreated patients; adjusted HR=12.82. All four deaths in the LAGEVRIO-treated group occurred in patients 60-64 years of age."

  • 13

    Oct

  • 27

    Oct

  • 29

    Jan

OTHER BREAKING NEWS FROM THE FLY

Conference/Events
Symbotic management to meet with Needham » 13:39
12/06/22
12/06
13:39
12/06/22
13:39
SYM

Symbotic

$11.62 /

+0.455 (+4.08%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYM Symbotic
$11.62 /

+0.455 (+4.08%)

SYM Symbotic
$11.62 /

+0.455 (+4.08%)

11/23/22 Deutsche Bank
Symbotic price target raised to $20 from $19 at Deutsche Bank
11/22/22 Baird
Symbotic price target lowered to $18 from $20 at Baird
11/22/22 Citi
Symbotic price target lowered to $16 from $21 at Citi
09/19/22 UBS
Symbotic initiated with a Buy at UBS
SYM Symbotic
$11.62 /

+0.455 (+4.08%)

SYM Symbotic
$11.62 /

+0.455 (+4.08%)

SYM Symbotic
$11.62 /

+0.455 (+4.08%)

Periodicals
Apple delays launch of self-driving car to 2026, Bloomberg reports  13:39
12/06/22
12/06
13:39
12/06/22
13:39
AAPL

Apple

$143.95 /

-2.66 (-1.81%)

 
ShowHide Related Items >><<
AAPL Apple
$143.95 /

-2.66 (-1.81%)

AAPL Apple
$143.95 /

-2.66 (-1.81%)

11:24 Today UBS
Apple iPhone 14 Pro/Pro Max delivery times finally easing, says UBS
12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
AAPL Apple
$143.95 /

-2.66 (-1.81%)

AAPL Apple
$143.95 /

-2.66 (-1.81%)

AAPL Apple
$143.95 /

-2.66 (-1.81%)

AAPL Apple
$143.95 /

-2.66 (-1.81%)

Hot Stocks
Novartis announces results from RIGHT Choice Phase II trial of Kisqali » 13:38
12/06/22
12/06
13:38
12/06/22
13:38
NVS

Novartis

$90.28 /

-0.71 (-0.78%)

Novartis announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$90.28 /

-0.71 (-0.78%)

NVS Novartis
$90.28 /

-0.71 (-0.78%)

12/05/22 Stifel
Novartis upgraded to Buy from Hold at Stifel
10/26/22 JPMorgan
Novartis price target lowered to CHF 78 from CHF 81 at JPMorgan
10/14/22 Barclays
Novartis price target lowered to CHF 75 from CHF 85 at Barclays
10/07/22 Deutsche Bank
Novartis price target lowered to CHF 70 from CHF 75 at Deutsche Bank
NVS Novartis
$90.28 /

-0.71 (-0.78%)

NVS Novartis
$90.28 /

-0.71 (-0.78%)

NVS Novartis
$90.28 /

-0.71 (-0.78%)

NVS Novartis
$90.28 /

-0.71 (-0.78%)

Conference/Events
Euronet CEO Brown to meet virtually with Northland » 13:36
12/06/22
12/06
13:36
12/06/22
13:36
EEFT

Euronet

$90.07 /

-1.62 (-1.77%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EEFT Euronet
$90.07 /

-1.62 (-1.77%)

EEFT Euronet
$90.07 /

-1.62 (-1.77%)

10/25/22 Citi
Euronet price target raised to $98 from $95 at Citi
10/09/22 Keefe Bruyette
Euronet downgraded to Market Perform from Outperform at Keefe Bruyette
10/06/22 DA Davidson
Euronet price target lowered to $140 from $170 at DA Davidson
10/04/22 Truist
Euronet price target lowered to $100 from $130 at Truist
EEFT Euronet
$90.07 /

-1.62 (-1.77%)

Options
Toll Brothers options imply 4.4% move in share price post-earnings » 13:34
12/06/22
12/06
13:34
12/06/22
13:34
TOL

Toll Brothers

$46.00 /

-0.91 (-1.94%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$46.00 /

-0.91 (-1.94%)

TOL Toll Brothers
$46.00 /

-0.91 (-1.94%)

11/22/22 JPMorgan
Toll Brothers upgraded to Overweight from Neutral at JPMorgan
10/21/22 Raymond James
Toll Brothers downgraded to Market Perform from Outperform at Raymond James
10/21/22 Raymond James
Toll Brothers downgraded to Market Perform from Outperform at Raymond James
09/19/22 KeyBanc
KeyBanc more bullish on homebuilder names, upgrades five stocks to Overweight
TOL Toll Brothers
$46.00 /

-0.91 (-1.94%)

TOL Toll Brothers
$46.00 /

-0.91 (-1.94%)

TOL Toll Brothers
$46.00 /

-0.91 (-1.94%)

TOL Toll Brothers
$46.00 /

-0.91 (-1.94%)

Syndicate
VinFast Auto files initial public offering » 13:26
12/06/22
12/06
13:26
12/06/22
13:26
VFS

VinFast Auto

/

+

VinFast Auto Ltd filed an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Vertex Energy call volume above normal and directionally bullish » 13:25
12/06/22
12/06
13:25
12/06/22
13:25
VTNR

Vertex Energy

$6.74 /

-0.33 (-4.67%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTNR Vertex Energy
$6.74 /

-0.33 (-4.67%)

VTNR Vertex Energy
$6.74 /

-0.33 (-4.67%)

08/10/22 Oppenheimer
Vertex Energy downgraded to Perform from Outperform at Oppenheimer
08/10/22 H.C. Wainwright
Vertex Energy price target lowered to $15 from $25 at H.C. Wainwright
07/07/22 Oppenheimer
Vertex Energy initiated with an Outperform at Oppenheimer
06/08/22 Stifel
Vertex Energy price target raised to $20 from $14 at Stifel
VTNR Vertex Energy
$6.74 /

-0.33 (-4.67%)

VTNR Vertex Energy
$6.74 /

-0.33 (-4.67%)

VTNR Vertex Energy
$6.74 /

-0.33 (-4.67%)

Conference/Events
BTIG policy director to hold an analyst/industry conference call » 13:25
12/06/22
12/06
13:25
12/06/22
13:25

Policy Research Director…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
PNC Financial CEO sees loan growth to exceed prior guidance » 13:22
12/06/22
12/06
13:22
12/06/22
13:22
PNC

PNC Financial

$150.01 /

-3.07 (-2.01%)

Asked about loan growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNC PNC Financial
$150.01 /

-3.07 (-2.01%)

PNC PNC Financial
$150.01 /

-3.07 (-2.01%)

12/01/22 Wolfe Research
PNC Financial price target raised to $170 from $164 at Wolfe Research
10/11/22 JPMorgan
PNC Financial price target lowered to $171.50 from $191 at JPMorgan
10/05/22 Morgan Stanley
PNC Financial price target lowered to $172 from $180 at Morgan Stanley
09/12/22 Deutsche Bank
PNC Financial price target lowered to $200 from $215 at Deutsche Bank
PNC PNC Financial
$150.01 /

-3.07 (-2.01%)

PNC PNC Financial
$150.01 /

-3.07 (-2.01%)

PNC PNC Financial
$150.01 /

-3.07 (-2.01%)

PNC PNC Financial
$150.01 /

-3.07 (-2.01%)

Earnings
Notable companies reporting before tomorrow's open » 13:22
12/06/22
12/06
13:22
12/06/22
13:22
BF.B

Brown-Forman

$73.50 /

-0.49 (-0.66%)

, BF.A

Brown-Forman

$73.30 /

-0.57 (-0.77%)

, CPB

Campbell Soup

$52.84 /

-0.475 (-0.89%)

, ASO

Academy Sports

$48.95 /

+0.66 (+1.37%)

, OLLI

Ollie's Bargain Outlet

$56.06 /

-1.27 (-2.22%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Brown-Forman (BF.B), consensus 55c... Campbell Soup (CPB), consensus 88c... Academy Sports and Outdoors (ASO), consensus $1.59... Ollie's Bargain Outlet (OLLI), consensus 41c.

ShowHide Related Items >><<
BF.B Brown-Forman
$73.50 /

-0.49 (-0.66%)

BF.A Brown-Forman
$73.30 /

-0.57 (-0.77%)

CPB Campbell Soup
$52.84 /

-0.475 (-0.89%)

ASO Academy Sports
$48.95 /

+0.66 (+1.37%)

OLLI Ollie's Bargain Outlet
$56.06 /

-1.27 (-2.22%)

BF.B Brown-Forman
$73.50 /

-0.49 (-0.66%)

10/10/22 Wedbush
Brown-Forman initiated with a Neutral at Wedbush
10/10/22 Wedbush
Brown-Forman initiated with a Neutral at Wedbush
09/28/22 Truist
Brown-Forman reinstated with a Buy at Truist
08/25/22 Barclays
Brown-Forman price target raised to $73 from $72 at Barclays
BF.A Brown-Forman
$73.30 /

-0.57 (-0.77%)

10/10/22 Wedbush
Brown-Forman initiated with a Neutral at Wedbush
10/10/22 Wedbush
Brown-Forman initiated with a Neutral at Wedbush
CPB Campbell Soup
$52.84 /

-0.475 (-0.89%)

11/15/22 Exane BNP Paribas
Campbell Soup initiated with an Underperform at Exane BNP Paribas
09/13/22 UBS
Campbell Soup's top-line guidance may be hard to achieve, says UBS
09/02/22 Piper Sandler
Campbell Soup price target lowered to $46 from $47 at Piper Sandler
08/25/22 JPMorgan
Campbell Soup price target raised to $49 from $46 at JPMorgan
ASO Academy Sports
$48.95 /

+0.66 (+1.37%)

11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
09/09/22 Loop Capital
Academy Sports initiated with a Buy at Loop Capital
09/08/22 UBS
Academy Sports price target raised to $60 from $55 at UBS
09/08/22 Evercore ISI
Academy Sports price target raised to $60 from $55 at Evercore ISI
OLLI Ollie's Bargain Outlet
$56.06 /

-1.27 (-2.22%)

10/24/22 Gordon Haskett
Ollie's Bargain Outlet initiated with a Buy at Gordon Haskett
09/16/22 JPMorgan
Ollie's Bargain Outlet price target raised to $54 from $40 at JPMorgan
09/02/22 Truist
Ollie's Bargain Outlet price target raised to $50 from $40 at Truist
08/30/22 Citi
Citi cautious into Ollie's results, opens 'negative catalyst watch'
BF.B Brown-Forman
$73.50 /

-0.49 (-0.66%)

BF.A Brown-Forman
$73.30 /

-0.57 (-0.77%)

CPB Campbell Soup
$52.84 /

-0.475 (-0.89%)

ASO Academy Sports
$48.95 /

+0.66 (+1.37%)

OLLI Ollie's Bargain Outlet
$56.06 /

-1.27 (-2.22%)

BF.B Brown-Forman
$73.50 /

-0.49 (-0.66%)

BF.A Brown-Forman
$73.30 /

-0.57 (-0.77%)

CPB Campbell Soup
$52.84 /

-0.475 (-0.89%)

ASO Academy Sports
$48.95 /

+0.66 (+1.37%)

CPB Campbell Soup
$52.84 /

-0.475 (-0.89%)

ASO Academy Sports
$48.95 /

+0.66 (+1.37%)

OLLI Ollie's Bargain Outlet
$56.06 /

-1.27 (-2.22%)

CPB Campbell Soup
$52.84 /

-0.475 (-0.89%)

ASO Academy Sports
$48.95 /

+0.66 (+1.37%)

Earnings
Notable companies reporting after market close » 13:20
12/06/22
12/06
13:20
12/06/22
13:20
MDB

MongoDB

$143.39 /

-5.34 (-3.59%)

, S

SentinelOne

$13.98 /

-0.28 (-1.96%)

, SFIX

Stitch Fix

$3.79 /

-0.245 (-6.07%)

Notable companies…

Notable companies reporting after the market close, with earnings consensus, include MongoDB (MDB), consensus (17c)... SentinelOne (S), consensus (22c)... Stitch Fix (SFIX), consensus (47c).

ShowHide Related Items >><<
MDB MongoDB
$143.39 /

-5.34 (-3.59%)

S SentinelOne
$13.98 /

-0.28 (-1.96%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

MDB MongoDB
$143.39 /

-5.34 (-3.59%)

12/05/22 Baird
MongoDB price target lowered to $205 from $330 at Baird
11/29/22 UBS
MongoDB price target lowered to $200 from $390 at UBS
11/21/22 Morgan Stanley
MongoDB downgraded at Morgan Stanley amid challenging spending environment
11/21/22 KeyBanc
MongoDB initiated with an Overweight at KeyBanc
S SentinelOne
$13.98 /

-0.28 (-1.96%)

12/01/22 Redburn
SentinelOne initiated with a Neutral at Redburn
11/29/22 Barclays
SentinelOne price target lowered to $20 from $33 at Barclays
11/23/22 BTIG
SentinelOne price target lowered to $25 from $38 at BTIG
11/22/22 Morgan Stanley
SentinelOne price target lowered to $30 from $40 at Morgan Stanley
SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

09/22/22 Barclays
Stitch Fix price target lowered to $5 from $7 at Barclays
09/21/22 Truist
Stitch Fix price target lowered to $6 from $8 at Truist
09/21/22 Evercore ISI
Stitch Fix price target lowered to $7 from $10 at Evercore ISI
09/21/22 MKM Partners
Stitch Fix price target lowered to $5 from $6 at MKM Partners
MDB MongoDB
$143.39 /

-5.34 (-3.59%)

S SentinelOne
$13.98 /

-0.28 (-1.96%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

S SentinelOne
$13.98 /

-0.28 (-1.96%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

MDB MongoDB
$143.39 /

-5.34 (-3.59%)

S SentinelOne
$13.98 /

-0.28 (-1.96%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

MDB MongoDB
$143.39 /

-5.34 (-3.59%)

S SentinelOne
$13.98 /

-0.28 (-1.96%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

Options
Stitch Fix options imply 15.1% move in share price post-earnings » 13:19
12/06/22
12/06
13:19
12/06/22
13:19
SFIX

Stitch Fix

$3.79 /

-0.245 (-6.07%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

09/22/22 Barclays
Stitch Fix price target lowered to $5 from $7 at Barclays
09/21/22 Truist
Stitch Fix price target lowered to $6 from $8 at Truist
09/21/22 Evercore ISI
Stitch Fix price target lowered to $7 from $10 at Evercore ISI
09/21/22 MKM Partners
Stitch Fix price target lowered to $5 from $6 at MKM Partners
SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

SFIX Stitch Fix
$3.79 /

-0.245 (-6.07%)

Technical Analysis
NASDAQ market internals summary » 13:17
12/06/22
12/06
13:17
12/06/22
13:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 13:16
12/06/22
12/06
13:16
12/06/22
13:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Conference/Events
DHI Group management to meet with Barrington » 13:08
12/06/22
12/06
13:08
12/06/22
13:08
DHX

DHI Group

$5.40 /

-0.07 (-1.28%)

Meeting to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DHX DHI Group
$5.40 /

-0.07 (-1.28%)

DHX DHI Group
$5.40 /

-0.07 (-1.28%)

11/03/22 B. Riley
DHI Group price target raised to $10 from $9 at B. Riley
10/04/22 Barrington
DHI Group initiated with an Outperform at Barrington
05/05/22 B. Riley
DHI Group price target raised to $9 from $8.50 at B. Riley
02/09/22 B. Riley
DHI Group price target raised to $8.50 from $7.50 at B. Riley
DHX DHI Group
$5.40 /

-0.07 (-1.28%)

DHX DHI Group
$5.40 /

-0.07 (-1.28%)

Conference/Events
Merit Medical management to meet with Barrington » 13:05
12/06/22
12/06
13:05
12/06/22
13:05
MMSI

Merit Medical

$70.71 /

-0.3 (-0.42%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MMSI Merit Medical
$70.71 /

-0.3 (-0.42%)

MMSI Merit Medical
$70.71 /

-0.3 (-0.42%)

11/07/22 Canaccord
Merit Medical price target raised to $73 from $69 at Canaccord
10/27/22 Canaccord
Merit Medical price target raised to $69 from $63 at Canaccord
10/27/22 Piper Sandler
Merit Medical price target raised to $73 from $70 at Piper Sandler
10/14/22 Canaccord
Merit Medical price target lowered to $63 from $69 at Canaccord
MMSI Merit Medical
$70.71 /

-0.3 (-0.42%)

MMSI Merit Medical
$70.71 /

-0.3 (-0.42%)

MMSI Merit Medical
$70.71 /

-0.3 (-0.42%)

Periodicals
Morgan Stanley laid off 2% of global staff, CNBC reports » 13:05
12/06/22
12/06
13:05
12/06/22
13:05
MS

Morgan Stanley

$86.95 /

-2.87 (-3.20%)

Morgan Stanley cut about…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MS Morgan Stanley
$86.95 /

-2.87 (-3.20%)

MS Morgan Stanley
$86.95 /

-2.87 (-3.20%)

10/18/22 BMO Capital
Morgan Stanley price target lowered to $95 from $97 at BMO Capital
10/17/22 Oppenheimer
Morgan Stanley price target lowered to $88 from $93 at Oppenheimer
10/17/22 Citi
Morgan Stanley price target lowered to $90 from $97 at Citi
10/17/22 Barclays
Morgan Stanley price target lowered to $105 from $108 at Barclays
MS Morgan Stanley
$86.95 /

-2.87 (-3.20%)

MS Morgan Stanley
$86.95 /

-2.87 (-3.20%)

MS Morgan Stanley
$86.95 /

-2.87 (-3.20%)

MS Morgan Stanley
$86.95 /

-2.87 (-3.20%)

Options
MongoDB options imply 13.7% move in share price post-earnings » 13:04
12/06/22
12/06
13:04
12/06/22
13:04
MDB

MongoDB

$143.60 /

-5.13 (-3.45%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDB MongoDB
$143.60 /

-5.13 (-3.45%)

MDB MongoDB
$143.60 /

-5.13 (-3.45%)

12/05/22 Baird
MongoDB price target lowered to $205 from $330 at Baird
11/29/22 UBS
MongoDB price target lowered to $200 from $390 at UBS
11/21/22 Morgan Stanley
MongoDB downgraded at Morgan Stanley amid challenging spending environment
11/21/22 KeyBanc
MongoDB initiated with an Overweight at KeyBanc
MDB MongoDB
$143.60 /

-5.13 (-3.45%)

MDB MongoDB
$143.60 /

-5.13 (-3.45%)

MDB MongoDB
$143.60 /

-5.13 (-3.45%)

Conference/Events
ModivCare management to meet with Barrington » 13:03
12/06/22
12/06
13:03
12/06/22
13:03
MODV

ModivCare

$84.94 /

+2.82 (+3.43%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MODV ModivCare
$84.94 /

+2.82 (+3.43%)

MODV ModivCare
$84.94 /

+2.82 (+3.43%)

11/04/22 Barrington
ModivCare price target lowered to $138 from $157 at Barrington
08/05/22 Barrington
ModivCare price target raised to $157 from $155 at Barrington
08/02/22 Stephens
ModivCare initiated with an Overweight at Stephens
05/06/22 Deutsche Bank
ModivCare price target lowered to $130 from $150 at Deutsche Bank
MODV ModivCare
$84.94 /

+2.82 (+3.43%)

Conference/Events
Superior Group management to meet virtually with Barrington » 13:02
12/06/22
12/06
13:02
12/06/22
13:02
SGC

Superior Group

$9.88 /

+0.035 (+0.36%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGC Superior Group
$9.88 /

+0.035 (+0.36%)

SGC Superior Group
$9.88 /

+0.035 (+0.36%)

08/25/22 Barrington
Superior Group price target lowered to $22 from $31 at Barrington
05/09/22 Barrington
Superior Group price target lowered to $31 from $33 at Barrington
SGC Superior Group
$9.88 /

+0.035 (+0.36%)

Hot Stocks
Apple updates App Store pricing, offers 700 new price points » 13:02
12/06/22
12/06
13:02
12/06/22
13:02
AAPL

Apple

$144.08 /

-2.53 (-1.73%)

Apple announced "the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$144.08 /

-2.53 (-1.73%)

AAPL Apple
$144.08 /

-2.53 (-1.73%)

11:24 Today UBS
Apple iPhone 14 Pro/Pro Max delivery times finally easing, says UBS
12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
AAPL Apple
$144.08 /

-2.53 (-1.73%)

AAPL Apple
$144.08 /

-2.53 (-1.73%)

AAPL Apple
$144.08 /

-2.53 (-1.73%)

AAPL Apple
$144.08 /

-2.53 (-1.73%)

Conference/Events
Cross Country Healthcare management to meet virtually with Barrington » 13:00
12/06/22
12/06
13:00
12/06/22
13:00
CCRN

Cross Country Healthcare

$34.16 /

-0.69 (-1.98%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCRN Cross Country Healthcare
$34.16 /

-0.69 (-1.98%)

CCRN Cross Country Healthcare
$34.16 /

-0.69 (-1.98%)

11/07/22 Barrington
Cross Country Healthcare price target raised to $45 from $41 at Barrington
10/05/22 Truist
Cross Country Healthcare downgraded to Hold at Truist on valuation
10/05/22 Truist
Cross Country Healthcare downgraded to Hold from Buy at Truist
09/15/22 Benchmark
Cross Country Healthcare price target raised to $42 from $37 at Benchmark
CCRN Cross Country Healthcare
$34.16 /

-0.69 (-1.98%)

CCRN Cross Country Healthcare
$34.16 /

-0.69 (-1.98%)

Hot Stocks
Walmart to pay $500,000 over workers' compensation prescription procedures » 13:00
12/06/22
12/06
13:00
12/06/22
13:00
WMT

Walmart

$150.17 /

-1.42 (-0.94%)

, WBA

Walgreens Boots Alliance

$40.63 /

-0.615 (-1.49%)

, CI

Cigna

$329.02 /

+1.38 (+0.42%)

Walmart (WMT) has agreed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$150.17 /

-1.42 (-0.94%)

WBA Walgreens Boots Alliance
$40.63 /

-0.615 (-1.49%)

CI Cigna
$329.02 /

+1.38 (+0.42%)

WMT Walmart
$150.17 /

-1.42 (-0.94%)

06:58 Today Bernstein
Walmart initiated with a Market Perform at Bernstein
12/01/22 Atlantic Equities
Walmart price target raised to $165 from $150 at Atlantic Equities
11/18/22 Gordon Haskett
Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner
11/17/22 Truist
Target price target lowered to $151 from $165 at Truist
WBA Walgreens Boots Alliance
$40.63 /

-0.615 (-1.49%)

11/23/22 Morgan Stanley
Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
11/22/22 Cowen
Walgreens upgraded to Outperform on services transition at Cowen
11/22/22 Cowen
Walgreens Boots Alliance upgraded to Outperform from Market Perform at Cowen
11/18/22 JPMorgan
Walgreens Boots Alliance upgraded to Overweight from Neutral at JPMorgan
CI Cigna
$329.02 /

+1.38 (+0.42%)

11/23/22 Morgan Stanley
Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
11/23/22 Morgan Stanley
Cigna assumed with an Overweight at Morgan Stanley
11/21/22 Raymond James
Cigna downgraded to Outperform from Strong Buy at Raymond James
11/21/22 Raymond James
Cigna downgraded to Outperform from Strong Buy at Raymond James
WMT Walmart
$150.17 /

-1.42 (-0.94%)

WBA Walgreens Boots Alliance
$40.63 /

-0.615 (-1.49%)

CI Cigna
$329.02 /

+1.38 (+0.42%)

WMT Walmart
$150.17 /

-1.42 (-0.94%)

WBA Walgreens Boots Alliance
$40.63 /

-0.615 (-1.49%)

CI Cigna
$329.02 /

+1.38 (+0.42%)

WMT Walmart
$150.17 /

-1.42 (-0.94%)

WBA Walgreens Boots Alliance
$40.63 /

-0.615 (-1.49%)

CI Cigna
$329.02 /

+1.38 (+0.42%)

WMT Walmart
$150.17 /

-1.42 (-0.94%)

WBA Walgreens Boots Alliance
$40.63 /

-0.615 (-1.49%)

Conference/Events
Climb Global management to meet virtually with Barrington » 12:58
12/06/22
12/06
12:58
12/06/22
12:58
CLMB

Climb Global

$33.00 /

+0.4 (+1.23%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLMB Climb Global
$33.00 /

+0.4 (+1.23%)

Options
Academy Sports and Outdoors put volume heavy and directionally bearish » 12:55
12/06/22
12/06
12:55
12/06/22
12:55
ASO

Academy Sports

$48.91 /

+0.62 (+1.28%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASO Academy Sports
$48.91 /

+0.62 (+1.28%)

ASO Academy Sports
$48.91 /

+0.62 (+1.28%)

11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
09/09/22 Loop Capital
Academy Sports initiated with a Buy at Loop Capital
09/08/22 UBS
Academy Sports price target raised to $60 from $55 at UBS
09/08/22 Evercore ISI
Academy Sports price target raised to $60 from $55 at Evercore ISI
ASO Academy Sports
$48.91 /

+0.62 (+1.28%)

ASO Academy Sports
$48.91 /

+0.62 (+1.28%)

ASO Academy Sports
$48.91 /

+0.62 (+1.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.